Intraocular Pressure Reduction and Complications Profile of Trabeculectomy with 5 Fluorouracil Versus Phaco-trabeculectomy with 5 Fluorouracil in Nigerian Glaucoma Patients
Ophthalmology Research: An International Journal,
Aims: To evaluate the surgical outcome of combined phacoemulsification cataract surgery plus posterior chamber intraocular and trabeculectomy with adjunctive 5-Fluorouracil versus trabeculectomy with 5-Fluorouracil in the management of Primary open angle glaucoma.
Study Design: it was retrospective comparative interventional study
Place and Duration of Study: Glaucoma Unit, Eye foundation Hospital Ikeja, Lagos, Nigeria between January 2015, and December 2017
Materials and Methods: A retrospective review of consecutive 29 eyes (29 patients) who had trabeculectomy with 5-Fluorouracil compared with 26 eyes (26 patients) who had combined phacotrabeculectomy with 5-Fluorouracil from 2015 to 2017. All patients had a minimum follow up of 3 months.
Results: The mean age of 54.48±14.42 years in Trabeculectomy group was significantly (p>0.001) lower than 70.76±7.22 years for the Phacotrabeculectomy group. The mean preoperative intraocular pressure (IOP) and number of glaucoma medication were similar for the two groups (19.86±9.63mmHg versus 22.23±8.99mmHg; 2.66±1.20 versus 2.73±0.72 medication, trabeculectomy versus phacotrabeculectomy respectively). The postoperative IOP and glaucoma medication after a mean follow up period of 17.11±9.81 months was not significantly different between the two groups (11.55±2.71mmHg versus 12.31±4.33mmHg, p=0.436 for trabeculectomy versus phacotrabeculectomy respectively). Both groups significantly required fewer number of antiglaucoma medication at final follow-up (1.14±0.92 vs 1.46±1.10, trabeculectomy vs phacotrabeculectomy. In the trabeculectomy group, 25 (86.2%) had IOP of ≤15mmHg with or without topical antiglaucoma drops. In the phacotrabeculectomy, 21 (80.76%) had IOP of ≤15mmHg with or without topical antiglaucoma medication (Qualified success). On the other hand, 8 (27.58%) had IOP of ≤15mmHg without topical antiglaucoma medication at the end of the follow-up in the trabeculectomy (Complete success). In the phacotrabeculectomy group, 5 (19.23%) had final IOP of ≤15mmHg without topical antiglaucoma medication.
Few complications occurred in both groups.
Conclusion: Phacotrabeculectomy augmented with 5-Fluorouracil gave comparable surgical success to 5-Fluorouracil augmented trabeculectomy alone.
- glaucoma patients
How to Cite
Augustinus CJ, Zeyen T. The effect of phacoemulsification and combined phaco/glaucoma procedures on the intraocular pressure in open-angle glaucoma. A review of the literature. Bull Soc Belge Ophthalmol. 2012;320:51-66.
Bonnie NKC. Comparison of surgical outcome of trabeculectomy and phacotrabeculectomy in Chinese glaucoma patients. 2017;10(12):1928–1930.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262‐7.
Ogata-Iwao M, Inatani M, Takihara Y, Inoue T, Iwao K, Tanihara H. A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C. Acta Ophthalmol. 2013;91(6):e500–e501.
Shingleton BJ, Gamell LS, O’Donoghue MW, et al. Long-term changes in intraocular pressure after clear corneal phacoemulsification: Normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999; 25:885-890.
Anderson DR, Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Current Opinion in Ophthalmology. 2003;14(2):86‐90.
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early manifest glaucoma trial group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L. Medical interventions for Primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2007;17:CD003167.
Gimbel HV, Meyer D, DeBroff BM et al. intraocular pressure response to combined phacoemulsification and trabeculectomy ab externo versus phacoemulsification alone in primary open-angle glaucoma. J Cataract Refract Surg. 1995;21:635-660.
Kleinmann G, Katz H, Pollack A, Schechtman E, Rachmiel R, Zalish M. Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation. Ophthalmic Surg Lasers. 2002;33:102– 108.
Singh RP, Goldberg I, Mohsin M. The efficacy and safety of intraoperative and/or postoperative 5-Fluorouracil in trabeculectomy and phacotrabeculectomy. Clin Exp Ophthalmol 2001;29:296-302.
Chang L, Thiagarajan M, Mosely M, Woodruff S, Bentley C, Khaw PT, et al. Intraocular pressure outcome in Primary 5FU phacotrabeculectomies compared with 5 FU trabeculectomies. J Glaucoma. 2006;15:475-481.
Siriwardena D, Kotecha A, Minassian D, et al. Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol. 2000; 84:1056–1057. (inflammatory mediators)
Jampel HD, Friedman DS, Lubomski LH, et al. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: an evidence-based review. Ophthalmology. 2002;109:2215–2224.
Anand N, Dawda VK. A comparative study of Mitomycin C and 5-Fluorouracil Trabeculectomy in West Africa. Middle East Afri J Ophthalmol. 2012;19:147-152.
De Fend LT, Arruda GV, Scott IU, Paula JS. Mitomycin C versus 5-Fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials. Clin Exp Ophthalmol 2013;41:798-806.
Wyse T, Meyer M, Ruderman JM, Krupin T, Talluto D, Hernandez R et al. Combined trabeculectomy and phacoemulsification: a one-site vs a two-site approach. Am J Ophthalmol. 1998; 125:334-339.
Abstract View: 89 times
PDF Download: 30 times